Evaluation of anticancer role of a novel ruthenium(II)-based compound compared with NAMI-A and cisplatin in impairing mitochondrial functionality and promoting oxidative stress in triple negative breast cancer models.

Mitochondrion
Sonia SilvestriAugusto Amici

Abstract

Platinum-based compounds are the most widely used anticancer drugs but, their elevated toxicity and chemoresistance has stimulated the study of others, such as ruthenium-based compounds. NAMI-A and UNICAM-1 were tested in vitro, comparing the mechanisms of toxicity, in terms of mitochondrial functionality and cellular oxidative stress. UNICAM-1, showed a clear mitochondrial target and a cytotoxic dose-dependent response thanks to its ability to promote an imbalance of cellular redox status. It impaired directly mitochondrial respiratory chain, promoting mitochondrial superoxide anion production, leading to mitochondrial membrane depolarization. All these aspects, could make UNICAM-1 a valid alternative for chemotherapy treatment of breast cancer.

References

Jun 17, 1998·Clinical & Experimental Metastasis·G SavaG Mestroni
Mar 4, 2000·Clinica Chimica Acta; International Journal of Clinical Chemistry·G S DeviP P Reddy
Oct 6, 2000·Medical Hypotheses·Q KongK O Lillehei
Jul 5, 2001·Toxicology and Applied Pharmacology·N DehneH de Groot
May 27, 2003·Apoptosis : an International Journal on Programmed Cell Death·R LiD W C Hunt
Nov 12, 2003·Cancer Chemotherapy and Pharmacology·Elizabeth Oldham HilemanPeng Huang
Dec 4, 2003·Biochemical Society Transactions·L BehrendR M Zwacka
Dec 9, 2003·The Journal of Biological Chemistry·Sun Young ParkMyung-Shik Lee
May 26, 2004·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Helene PelicanoPeng Huang
Nov 4, 2004·Integrative Cancer Therapies·Kenneth A Conklin
Dec 8, 2004·Current Topics in Medicinal Chemistry·Enzo AlessioGianni Sava
Jun 10, 2005·Journal of Medicinal Chemistry·Claudine ScolaroPaul J Dyson
Jun 25, 2005·Carcinogenesis·Mirco GalièAndrea Sbarbati
May 27, 2006·Science·Satoaki MatobaPaul M Hwang
Jul 25, 2006·Nature Reviews. Cancer·Andrew I Minchinton, Ian F Tannock
Oct 6, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Zejia YangKevin J Cullen
Jan 4, 2007·Journal of the American Chemical Society·Cindy A Puckett, Jacqueline K Barton
Aug 19, 2008·Free Radical Biology & Medicine·Lori A RowePaul W Doetsch
May 1, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F Muggia
Mar 10, 2010·Cancer Chemotherapy and Pharmacology·Emmanuel S Antonarakis, Ashkan Emadi
Jul 2, 2010·Dalton Transactions : an International Journal of Inorganic Chemistry·Nial J WheateRabbab Oun
Nov 1, 2009·Metallomics : Integrated Biometal Science·Aviva LevinaPeter A Lay
Mar 15, 2011·Metallomics : Integrated Biometal Science·Michael GroesslPaul J Dyson
Apr 14, 2012·Chemical Communications : Chem Comm·Andrea KurzwernhartChristian G Hartinger
May 23, 2012·Current Opinion in Pharmacology·Anne-Laure Lainé, Catherine Passirani
Oct 27, 2012·Breast Cancer Research : BCR·Brigitte BisaroPaola Defilippi
Mar 14, 2013·Metallomics : Integrated Biometal Science·Chen QianHui Chao
Nov 30, 2013·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Jin-Quan WangHui Chao
Dec 19, 2013·Frontiers in Oncology·Michelle L BolandKay F Macleod
Jul 22, 2014·Cancer·Vandana G AbramsonJennifer A Pietenpol
Jul 25, 2014·European Journal of Pharmacology·Shaloam Dasari, Paul Bernard Tchounwou

❮ Previous
Next ❯

Citations

Jan 21, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Nikita P Burlutskiy, Andrei S Potapov
Apr 8, 2021·Journal of Inorganic Biochemistry·Prinessa ChellanPeter J Sadler

❮ Previous
Next ❯

Related Concepts